Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jim Martineau"'
Autor:
Meggen Gullo, Xiaochuan (Tracy) Zhang, Jeet Mukherjee, Liang Xu, Reetabrata Mookherjee, Jim Martineau, Zhou Kailai, Ni Li, Andrew Hazlewood, Ferrari Griarte
Publikováno v:
Interfaces. 46:49-73
Ingram Micro, the world’s largest distributor of technology products, operates in a high-volume low-margin environment. The company started its Business Intelligence and Analytics practice in North America in 2009. This group has since built and de
Autor:
Anna Weinberg Chalmers, B. Haaland, Wallace Akerley, William A. Dunson, Shiven B. Patel, Jim Martineau, Laura Cannon, Tyler Haydell, Neal J. Meropol, Dominik Ose
Publikováno v:
Journal of Clinical Oncology. 36:8-8
8 Background: Performance status, which is prognostic of survival, is a physician’s interpretation of PROs. This retrospective study evaluated prognosis of PROs, independent of physician assessment, with overall survival (OS) and hospitalization-fr
Autor:
Jordan P. McPherson, Shiven B. Patel, Dominik Ose, Elena Igumnova, Anna C. Beck, Tyler Haydell, Jim Martineau, Neal J. Meropol, Jacob C. Pettit
Publikováno v:
Journal of Clinical Oncology. 36:303-303
303 Background: Aggressive medical interventions and associated high costs of care for cancer pts near the EOL are common. Addressing this issue at the local level requires an accurate, automated process to merge real-time clinical EHR data with cost
Autor:
B. Haaland, Anna Weinberg Chalmers, Dominik Ose, Tyler Haydell, Shiven B. Patel, Jim Martineau, Wallace Akerley, Neal J. Meropol, Laura Cannon, Betsy Kissell, William A. Dunson
Publikováno v:
Journal of Clinical Oncology. 36:10101-10101
10101Background: Performance status is often used to stratify cancer pts for treatment and to guide supportive care resources. This retrospective study was conducted to evaluate whether PROs have p...
Autor:
Kerin B. Adelson, James Hamrick, Tyler Haydell, Jim Martineau, Rogerio Lilenbaum, Joshua Kraut, Kimberly M Severino, Neal J. Meropol
Publikováno v:
Journal of Clinical Oncology. 36:6590-6590
6590Background: Accurate, reproducible, transparent and continuous healthcare utilization measures derived from structured EHR data may facilitate higher value cancer care at the end of life in bot...